华信HXZY品牌怎么样 申请店铺

外推网助力华信HXZY品牌出海！将品牌入驻外推网，定制华信HXZY品牌推广信息，可以显著提高华信HXZY产品曝光，简直是跨境电商爆单神器！目前仅需1000元/年哦~

山东华信制药集团创建于2002年3月，总部位于菏泽市高新技术产业园，拥有胶剂、大容量注射剂、片剂、颗粒剂、胶囊剂、口服溶液剂等10个剂型，均一次性顺利通过新版GMP认证。历经风雨十余载，华信集团完成了凤凰涅槃般地美丽蜕变，从一个名不见经传的小厂成长为集科研开发、药品制造、医药经贸于一体的现代化综合性制药集团。

山东华信制药集团自成立以来以“打造民族品牌”为己任，大力发展阿胶产业，加大华信阿胶系列产品的市场开发和拓展，对目标市场进行深耕细作，实施全员营销战略，以阿胶为品牌根基品种，与主要连锁经销商、零售商共同打造百城万家连锁终端市场，抓好终端市场的开发和以省级大区为单位的渠道网络建设，不断推出国食健字阿胶保健品以及阿胶食品，注重阿胶系列产品的规模化运作和规范化经营，实现阿胶全产业链运作，使华信集团向阿胶制品深加工、产业结构多元化、产品系列化、资本收益最大化的格局稳步发展。

华信集团新推出上呼吸道感染主打产品群——独家专利产品、国家三类新药：龙香平喘胶囊、伪麻那敏胶囊、美愈伪麻口服液等产品是公司近两年重点培育的新品种，这也是公司新的经济增长点，在全国的市场营销战略正全面推进，逐步构建以地级市为中心的覆盖各等级医院及社区门诊的销售网络和渠道。以新药龙香平喘胶囊、益中生血胶囊、紫丹活血胶囊、伪麻那敏胶囊、美愈伪麻口服溶液，饮片胶丁为主的临床终端产品正不断刷新销售记录，持续攀升市场占有率，实现终端市场的新突破。

华信制药集团将继续做好产品结构调整，企业转型升级，聚焦主推产品（阿胶、新药），实施大品种、大终端、大健康的发展战略，规范企业运作，建立完善现代企业制度，对接资本市场，建立健全药品全过程的质量控制体系，实行精细化管理，智能化制造，始终如一地追求药品的安全和显著的功能疗效，以实现华信的新腾飞。

Shandong Huaxin Pharmaceutical Group, founded in March 2002, is headquartered in Heze high tech Industrial Park. It has 10 dosage forms including gel, large volume injection, tablet, granule, capsule and oral solution, all of which have successfully passed the new GMP certification at one time. After more than ten years of ups and downs, Huaxin group has completed a beautiful transformation like Phoenix Nirvana, growing from an unknown small factory to a modern comprehensive pharmaceutical group integrating scientific research and development, pharmaceutical manufacturing and pharmaceutical trade. Since its establishment, Shandong Huaxin Pharmaceutical Group has taken "building a national brand" as its own duty, vigorously developed the gelatin industry, increased the market development and expansion of the gelatin series products of Huaxin, deeply cultivated the target market, implemented the marketing strategy of the whole staff, took the gelatin as the basic brand variety, and worked with the main chain dealers and retailers to build a chain terminal market of one hundred cities and ten thousand stores, to make the best of it The development of the end market and the construction of the channel network with the provincial region as the unit, continuously launched the national food Jianzi donkey hide gelatin health products and donkey hide gelatin food, paid attention to the large-scale operation and standardized operation of the donkey hide gelatin series products, realized the operation of the whole industrial chain of donkey hide gelatin, and made Huaxin group steadily distribute to the pattern of the deep processing of donkey hide gelatin products, the diversification of industrial structure, the serialization of products and the maximization of capital gains Exhibition. Huaxin group has newly launched the main product group of upper respiratory tract infection - exclusive patent products, three kinds of national new drugs: Longxiang Pingchuan capsule, pseudoephedrine capsule, Meiyu pseudoephedrine oral liquid and other products, which are the company's key cultivation new varieties in the past two years, which are also the company's new economic growth point. The national marketing strategy is being promoted in an all-round way, and gradually building a coverage centered on prefecture level cities Sales network and channels of all levels of hospitals and community clinics. The clinical terminal products, mainly composed of new drugs Longxiang Pingchuan capsule, Yizhong Shengxue capsule, Zidan Huoxue Capsule, pseudo Ma Namin capsule, Meiyu pseudo Ma oral solution, and decoction pieces Jiaoding, are constantly refreshing their sales records, continuously increasing their market share, and achieving new breakthroughs in the terminal market. Huaxin Pharmaceutical Group will continue to do a good job in product structure adjustment, enterprise transformation and upgrading, focus on the main products (donkey hide gelatin, new drugs), implement the development strategy of large varieties, large terminals and large health, standardize enterprise operation, establish and improve modern enterprise system, connect capital market, establish and improve the quality control system of the whole process of drugs, implement fine management and intelligent manufacturing, and always Such as the pursuit of drug safety and significant functional efficacy, in order to achieve the new take-off of Huaxin.

本文链接： https://brand.waitui.com/9d5f26ed9.html 联系电话：请联系客服添加 联系邮箱：请联系客服添加